CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial

AAM 17:05 Carl Zimmer, NYT > Top Stories

NYT > Top Stories Carl ZimmerA preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said. June 17, 2021 at 12:05AM https://ift.tt/3cOcw1J